R

Remiges Ventures, Inc.

10 employees

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Investor insights

Sectors invested in

Biotechnology10
Health Care7
Medical6
Therapeutics6
Pharmaceutical4
Life Science2
Drug development and Cardiovascular Research2
pandemic preparedness1
Gene therapy1
ophthalmology1
AAV1
retinitis pigmentosa1
Pharmaceuticals1
Nanotechnology1
Influenza1
Charcot-Marie-Tooth1
IFB-0881
Amyotrophic Lateral Scelrosis1
ALS1
Protein misfolding diseases1

Funding rounds participated in

$1.5M sweet spot round size

Most of their 15 investments are in rounds between $8.1M and $20M

Investor type

Venture Capital

Basic info

Sectors

Investments made

K

Kupando GmbH raised $13M on September 26, 2022

Investors: Brandenburg Kapital GmbH, High-Tech Gründerfonds and Remiges Ventures, Inc.

I

Immunis, Inc. raised $10M on August 3, 2022

Investors: Continuum Health Ventures and Remiges Ventures, Inc.

L

LUCA Science Inc. raised $30M on June 6, 2022

Investors: SMBCベンチャーキャピタル(株), 旭化成ファーマ(株), ニッセイ・キャピタル(株), NVCC, Fast Track Initiative and Remiges Ventures, Inc.

R

Restore Vision raised $2.6M on February 3, 2022

Investors: ANRI and Remiges Ventures, Inc.

C

Capacity Bio raised undisclosed on January 1, 2022

Investors: Remiges Ventures, Inc.

G

Glycomine Inc. raised $35M on June 23, 2021

Investors: Chiesi Ventures, RiverVest Venture Partners, Sanofi Ventures, Mission BioCapital, Abingworth, Novo Holdings and Remiges Ventures, Inc.

C

Cyrano Therapeutics raised $13M on December 10, 2020

Investors: Lumira Ventures and Remiges Ventures, Inc.

L

LUCA Science Inc. raised $9.8M on September 1, 2020

Investors: (株)カーク, Axil Capital Partners, Axil Capital Advisors K.K., Fast Track Initiative, NVCC and Remiges Ventures, Inc.

T

Tranquis Therapeutics, Inc. raised $30M on July 9, 2020

Investors: Correlation Ventures, Vivo Capital, S.R. One Ltd and Remiges Ventures, Inc.

O

OMEICOS Therapeutics GmbH raised $19M on November 2, 2018

Investors: KG Investments, LLC, Vesalius Biocapital, KfW, Forbion, High-Tech Gründerfonds and Remiges Ventures, Inc.

FAQ